vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Bank First Corp (BFC). Click either name above to swap in a different company.
Bank First Corp is the larger business by last-quarter revenue ($44.9M vs $44.9M, roughly 1.0× AbCellera Biologics Inc.). Bank First Corp runs the higher net margin — 45.8% vs -19.9%, a 65.7% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 12.1%). Bank First Corp produced more free cash flow last quarter ($51.0M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 9.1%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.
ABCL vs BFC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $44.9M |
| Net Profit | $-8.9M | $18.4M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 51.0% |
| Net Margin | -19.9% | 45.8% |
| Revenue YoY | 788.4% | 12.1% |
| Net Profit YoY | 73.9% | 4.8% |
| EPS (diluted) | $-0.03 | $1.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $44.9M | ||
| Q3 25 | $9.0M | $44.2M | ||
| Q2 25 | $17.1M | $41.6M | ||
| Q1 25 | $4.2M | $43.1M | ||
| Q4 24 | $5.0M | $40.1M | ||
| Q3 24 | $6.5M | $40.8M | ||
| Q2 24 | $7.3M | $38.9M | ||
| Q1 24 | $10.0M | $37.7M |
| Q4 25 | $-8.9M | $18.4M | ||
| Q3 25 | $-57.1M | $18.0M | ||
| Q2 25 | $-34.7M | $16.9M | ||
| Q1 25 | $-45.6M | $18.2M | ||
| Q4 24 | — | $17.5M | ||
| Q3 24 | $-51.1M | $16.6M | ||
| Q2 24 | $-36.9M | $16.1M | ||
| Q1 24 | $-40.6M | $15.4M |
| Q4 25 | -63.7% | 51.0% | ||
| Q3 25 | -851.8% | 50.8% | ||
| Q2 25 | -290.2% | 49.7% | ||
| Q1 25 | -1479.6% | 51.3% | ||
| Q4 24 | — | 54.4% | ||
| Q3 24 | -1439.4% | 50.7% | ||
| Q2 24 | -1276.2% | 51.0% | ||
| Q1 24 | -551.5% | 45.6% |
| Q4 25 | -19.9% | 45.8% | ||
| Q3 25 | -637.8% | 40.7% | ||
| Q2 25 | -203.3% | 40.5% | ||
| Q1 25 | -1077.2% | 42.3% | ||
| Q4 24 | — | 49.3% | ||
| Q3 24 | -785.4% | 40.6% | ||
| Q2 24 | -504.3% | 41.3% | ||
| Q1 24 | -408.0% | 40.8% |
| Q4 25 | $-0.03 | $1.87 | ||
| Q3 25 | $-0.19 | $1.83 | ||
| Q2 25 | $-0.12 | $1.71 | ||
| Q1 25 | $-0.15 | $1.82 | ||
| Q4 24 | — | $1.75 | ||
| Q3 24 | $-0.17 | $1.65 | ||
| Q2 24 | $-0.13 | $1.59 | ||
| Q1 24 | $-0.14 | $1.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $243.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $643.8M |
| Total Assets | $1.4B | $4.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $243.2M | ||
| Q3 25 | $83.2M | $126.2M | ||
| Q2 25 | $92.4M | $120.3M | ||
| Q1 25 | $159.3M | $300.9M | ||
| Q4 24 | $156.3M | $261.3M | ||
| Q3 24 | $126.6M | $204.4M | ||
| Q2 24 | $148.3M | $99.0M | ||
| Q1 24 | $123.6M | $83.4M |
| Q4 25 | $966.9M | $643.8M | ||
| Q3 25 | $964.0M | $628.1M | ||
| Q2 25 | $1.0B | $612.3M | ||
| Q1 25 | $1.0B | $648.4M | ||
| Q4 24 | $1.1B | $639.7M | ||
| Q3 24 | $1.1B | $628.9M | ||
| Q2 24 | $1.1B | $614.6M | ||
| Q1 24 | $1.1B | $609.3M |
| Q4 25 | $1.4B | $4.5B | ||
| Q3 25 | $1.4B | $4.4B | ||
| Q2 25 | $1.4B | $4.4B | ||
| Q1 25 | $1.3B | $4.5B | ||
| Q4 24 | $1.4B | $4.5B | ||
| Q3 24 | $1.4B | $4.3B | ||
| Q2 24 | $1.4B | $4.1B | ||
| Q1 24 | $1.5B | $4.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $62.5M |
| Free Cash FlowOCF − Capex | $-44.6M | $51.0M |
| FCF MarginFCF / Revenue | -99.4% | 113.6% |
| Capex IntensityCapex / Revenue | 21.9% | 25.5% |
| Cash ConversionOCF / Net Profit | — | 3.40× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $75.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $62.5M | ||
| Q3 25 | $-52.6M | $15.5M | ||
| Q2 25 | $-32.4M | $11.9M | ||
| Q1 25 | $-11.6M | $6.2M | ||
| Q4 24 | $-108.6M | $65.8M | ||
| Q3 24 | $-28.9M | $18.8M | ||
| Q2 24 | $-30.0M | $14.9M | ||
| Q1 24 | $-41.7M | $1.3M |
| Q4 25 | $-44.6M | $51.0M | ||
| Q3 25 | $-61.5M | $12.5M | ||
| Q2 25 | $-45.8M | $8.2M | ||
| Q1 25 | $-22.2M | $4.0M | ||
| Q4 24 | $-187.0M | $58.6M | ||
| Q3 24 | $-47.4M | $16.9M | ||
| Q2 24 | $-50.1M | $13.7M | ||
| Q1 24 | $-65.8M | $551.0K |
| Q4 25 | -99.4% | 113.6% | ||
| Q3 25 | -687.0% | 28.2% | ||
| Q2 25 | -267.9% | 19.8% | ||
| Q1 25 | -524.0% | 9.3% | ||
| Q4 24 | -3702.8% | 146.3% | ||
| Q3 24 | -728.4% | 41.5% | ||
| Q2 24 | -683.8% | 35.3% | ||
| Q1 24 | -661.5% | 1.5% |
| Q4 25 | 21.9% | 25.5% | ||
| Q3 25 | 99.7% | 6.7% | ||
| Q2 25 | 78.2% | 8.7% | ||
| Q1 25 | 251.1% | 5.0% | ||
| Q4 24 | 1552.7% | 18.0% | ||
| Q3 24 | 284.6% | 4.5% | ||
| Q2 24 | 274.6% | 3.1% | ||
| Q1 24 | 242.5% | 2.1% |
| Q4 25 | — | 3.40× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 3.75× | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 0.93× | ||
| Q1 24 | — | 0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
